Page 1 | Search Results | Blood | American Society of Hematology

1-6 of 6

Sort by

Sort Order Select

Journal Articles

Requirement for CDK6 in MLL-rearranged acute myeloid leukemia

Theresa Placke, Katrin Faber, Atsushi Nonami, Sarah L. Putwain, Helmut R. Salih, Florian H. Heidel, Alwin Krämer, David E. Root, David A. Barbie, Andrei V. Krivtsov, Scott A. Armstrong, William C. Hahn, Brian J. Huntly, Stephen M. Sykes, Michael D. Milsom, Claudia Scholl, Stefan Fröhling

Blood (2014) 124 (1): 13–23.

https://doi.org/10.1182/blood-2014-02-558114

Published: 2014

Includes: Supplemental data

Journal Articles

Requirement For CDK6 In MLL-Rearranged Acute Myeloid Leukemia

Theresa Placke, PhD, Katrin Faber, PhD, Atsushi Nonami, MD, Helmut R. Salih, MD, Stephen M. Sykes, PhD, David E. Root, PhD, David A. Barbie, MD, William C. Hahn, MD, PhD, Michael D. Milsom, PhD, Claudia Scholl, MD, Stefan Fröhling, MD

Blood (2013) 122 (21): 3782.

https://doi.org/10.1182/blood.V122.21.3782.3782

Published: 2013

Journal Articles

Pseudoexpression of Glucocorticoid-Induced TNF-Related (GITR) Ligand Upon Coating of Cancer Cells by Platelets Impairs NK Cell Anti-Tumor Reactivity

Theresa Placke, Lothar Kanz, MD, Helmut R. Salih, MD, Hans-Georg Kopp, MD

Blood (2010) 116 (21): 3193.

https://doi.org/10.1182/blood.V116.21.3193.3193

Published: 2010

Journal Articles

Transfer of MHC Class I by Coating Platelets Enables Tumor Cells to Evade NK Cell Immune Surveillance by Conferring a “Pseudo Self” Phenotype

Theresa Placke, Hans-Georg Kopp, MD, Martin Schaller, MD, Gundram Jung, MD, Lothar Kanz, MD, Helmut R. Salih, MD

Blood (2010) 116 (21): 583.

https://doi.org/10.1182/blood.V116.21.583.583

Published: 2010

Journal Articles

Coating of Tumor Cells by Platelets Confers Expression of Immunoregulatory Molecules Which Impair NK Cell Anti-Tumor Reactivity.

Theresa Placke, Hans-Georg Kopp, MD, Lothar Kanz, MD, Helmut R Salih, MD

Blood (2009) 114 (22): 2993.

https://doi.org/10.1182/blood.V114.22.2993.2993

Published: 2009

Journal Articles

NK Cell Anti-Tumor Reactivity Is Impaired by Platelet-Derived TGF-B through NKG2D Downregulation

Hans-Georg Kopp, Theresa Placke, Benjamin J Schmiedel, Lothar Kanz, MD, Matthias Krusch, Helmut R Salih, MD

Blood (2008) 112 (11): 2859.

https://doi.org/10.1182/blood.V112.11.2859.2859

Published: 2008

NARROW

Requirement for CDK6 in MLL-rearranged acute myeloid leukemia

Requirement For CDK6 In MLL-Rearranged Acute Myeloid Leukemia

Pseudoexpression of Glucocorticoid-Induced TNF-Related (GITR) Ligand Upon Coating of Cancer Cells by Platelets Impairs NK Cell Anti-Tumor Reactivity

Transfer of MHC Class I by Coating Platelets Enables Tumor Cells to Evade NK Cell Immune Surveillance by Conferring a “Pseudo Self” Phenotype

Coating of Tumor Cells by Platelets Confers Expression of Immunoregulatory Molecules Which Impair NK Cell Anti-Tumor Reactivity.

NK Cell Anti-Tumor Reactivity Is Impaired by Platelet-Derived TGF-B through NKG2D Downregulation

Email alerts

ASH Publications

American Society of Hematology

Requirement for CDK6 in MLL-rearranged acute myeloid leukemia

Requirement For CDK6 In MLL-Rearranged Acute Myeloid Leukemia

Pseudoexpression of Glucocorticoid-Induced TNF-Related (GITR) Ligand Upon Coating of Cancer Cells by Platelets Impairs NK Cell Anti-Tumor Reactivity

Transfer of MHC Class I by Coating Platelets Enables Tumor Cells to Evade NK Cell Immune Surveillance by Conferring a “Pseudo Self” Phenotype

Coating of Tumor Cells by Platelets Confers Expression of Immunoregulatory Molecules Which Impair NK Cell Anti-Tumor Reactivity.

NK Cell Anti-Tumor Reactivity Is Impaired by Platelet-Derived TGF-B through NKG2D Downregulation

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only